Negative Regulation of Stat3 by ActivatingPTPN11Mutants Contributes to the Pathogenesis of Noonan Syndrome and Juvenile Myelomonocytic Leukemia

作者: Wenjun Zhang , Rebecca J. Chan , Hanying Chen , Zhenyun Yang , Yantao He

DOI: 10.1074/JBC.M109.020495

关键词:

摘要: Noonan syndrome (NS) is an autosomal dominant congenital disorder characterized by multiple birth defects including heart and myeloproliferative disease (MPD). Approximately 50% of NS patients have germline gain-of-function mutations in PTPN11, which encodes the protein-tyrosine phosphatase, Shp2. We provide evidence that conditional ablation Stat3 hematopoietic cells cardiac valvular tissues leads to myeloid progenitor hyperplasia pulmonary stenosis due leaflet thickening, respectively. Consistently, STAT3 activation significantly compromised peripheral blood from bearing Shp2-activating mutations. Biochemical functional analyses demonstrate activated Shp2 able down-regulate Tyr(P)-Stat3 constitutively active rescues activating mutant Shp2-induced granulocyte-macrophage colony-stimulating factor hypersensitivity bone marrow cells. Collectively, our work demonstrates essential signaling component potentially contributing pathogenesis juvenile myelomonocytic leukemia caused PTPN11

参考文章(50)
Marco Tartaglia, Ernest L. Mehler, Rosalie Goldberg, Giuseppe Zampino, Han G. Brunner, Hannie Kremer, Ineke van der Burgt, Andrew H. Crosby, Andra Ion, Steve Jeffery, Kamini Kalidas, Michael A. Patton, Raju S. Kucherlapati, Bruce D. Gelb, Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nature Genetics. ,vol. 29, pp. 465- 468 ,(2001) , 10.1038/NG772
Yuhong Chen, Renren Wen, Shoua Yang, James Schuman, Eric E Zhang, Taolin Yi, Gen-Sheng Feng, Demin Wang, None, IDENTIFICATION OF SHP-2 AS A STAT5A PHOSPHATASE Journal of Biological Chemistry. ,vol. 278, pp. 16520- 16527 ,(2003) , 10.1074/JBC.M210572200
Anna Sarkozy, Claudio Carta, Sonia Moretti, Giuseppe Zampino, Maria C Digilio, Francesca Pantaleoni, Anna Paola Scioletti, Giorgia Esposito, Viviana Cordeddu, Francesca Lepri, Valentina Petrangeli, Maria L Dentici, Grazia MS Mancini, Angelo Selicorni, Cesare Rossi, Laura Mazzanti, Bruno Marino, Giovanni B Ferrero, Margherita Cirillo Silengo, Luigi Memo, Franco Stanzial, Francesca Faravelli, Liborio Stuppia, Efisio Puxeddu, Bruce D Gelb, Bruno Dallapiccola, Marco Tartaglia, None, Germline BRAF mutations in noonan, LEOPARD, and cardiofaciocutaneous Syndromes: Molecular diversity and associated phenotypic spectrum Human Mutation. ,vol. 30, pp. 695- 702 ,(2009) , 10.1002/HUMU.20955
Jacqueline Bromberg, James E Darnell, The role of STATs in transcriptional control and their impact on cellular function Oncogene. ,vol. 19, pp. 2468- 2473 ,(2000) , 10.1038/SJ.ONC.1203476
Zhong-Qing Shi, De-Hua Yu, Morag Park, Mark Marshall, Gen-Sheng Feng, Molecular Mechanism for the Shp-2 Tyrosine Phosphatase Function in Promoting Growth Factor Stimulation of Erk Activity Molecular and Cellular Biology. ,vol. 20, pp. 1526- 1536 ,(2000) , 10.1128/MCB.20.5.1526-1536.2000
David E. Levy, Chien-kuo Lee, What does Stat3 do Journal of Clinical Investigation. ,vol. 109, pp. 1143- 1148 ,(2002) , 10.1172/JCI15650
Rebecca J. Chan, Melissa B. Leedy, Veerendra Munugalavadla, Cara S. Voorhorst, Yanjun Li, Menggang Yu, Reuben Kapur, Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor Blood. ,vol. 105, pp. 3737- 3742 ,(2005) , 10.1182/BLOOD-2004-10-4002
Gen-Sheng Feng, Shp-2 Tyrosine Phosphatase: Signaling One Cell or Many Experimental Cell Research. ,vol. 253, pp. 47- 54 ,(1999) , 10.1006/EXCR.1999.4668